This article was originally published in The Gray Sheet
Executive SummaryCompany President Elizabeth Davila named CEO, effective Feb. 13. Outgoing CEO Mark Logan will remain board chairman until firm's next annual meeting. Separately, Federal Trade Commission drops suit against Visx following Patent and Trademark Office's issuance of a reexamination certificate for Visx's '388 patent. FTC had appealed a June 1999 FTC administrative law judge dismissal of the patent fraud complaint (1"The Gray Sheet" June 28, 1999, In Brief)
You may also be interested in...
The Mallorca-based biotech is building a strong data package for SNF472 which the company believes will be an effective treatment for a number of calcification disorders in dialysis patients.
India’s Sun Pharma has been denied leave to appeal against a US court decision rejecting the company’s bid for dismissal of a multi-district antitrust lawsuit.